Women’s Health MASTERCLASS 2026

Get tailored sparring and direct feedback on your company’s strategy within women’s health. In this women’s health masterclass, you will work closely with international experts and like-minded companies to strengthen your business, sharpen your position and accelerate the path from idea to market – based on your specific challenges and opportunities.

About the Masterclass

The Women’s Health MASTERCLASS 2026 is a practical and highly interactive two-day program designed for a small group of women’s health companies that want to strengthen their strategy, accelerate growth, and better understand the future of healthcare innovation. The masterclass combines real-world experience, open discussions, case studies, and hands-on working sessions focused on women’s health, clinical validation, commercialization, and partnerships.

Participation is limited to three to five selected women’s health SMEs and startups to facilitate close dialogue, direct feedback, and meaningful collaboration. The masterclass has been developed in collaboration between Innovation Centre Denmark and The Danish Life Science Cluster (DLSC) and will be conducted in English.

Funding

The program is be supported through available de minimis funding frameworks, covering up to 100% of participation costs.

Topics will include

Future trends in women’s health, new technologies, clinical evidence and healthcare adoption, commercialization and partnerships, international market opportunities & lessons from successful and unsuccessful women’s health-tech companies. The content and discussions will be updated and adjusted according to the participating companies, their technologies, challenges, and priorities.

Masterclass Format

First day (September 2)

  • Interactive workshops and strategic working sessions
  • Startup presentations and pitch sessions
  • Direct expert feedback from Prof. Avi Tsur and Yonat Granot
  • Round tables discussions with all participants

Second day (September 3)

  • Individual 2-hour advisory session with Prof. Avi Tsur for each participating company

Expected Outcomes

  • Clearer strategic direction
  • Stronger understanding of clinical and commercial pathways
  • Practical feedback tailored to their company
  • Access to valuable network of innovators and stakeholders in women’s health
  • Valuable international connections and insights
  • Tailored recommendations and actionable next steps

Speakers

Led by Professor Avi Tsur, MD, MBA

  • Founder and Director; Hybrid High-Risk Antepartum Unit “Beyond”
  • Chief Medical Officer; ARC Innovation & Sheba AI Center
  • Director; Sheba ARC Women’s Health Innovation Center
  • Vice Dean; Recanati School of Medicine, Reichman University

Apply before August 25.

Similar upcoming events